Ophthalmology Management

07/22/2025

Tuesday Tip: After years of grinding through residency and fellowship, you finally have the title you’ve been working toward: attending physician! But attaining this title isn’t the end of the marathon—it’s the beginning of a whole new leg. Think of week 1 as a chance to learn the system and set yourself up for success. Learn every team member’s name and preferred communication style. Spend some time observing a seasoned tech or scheduler to better understand the clinic and OR flow.

For more tips to help you navigate those first weeks with confidence, read the full article by Victoria Wang, MD, MS, and Lisa M. Nijm, MD, JD, Real World Ophthalmology, at https://ophthalmologymanagement.com/issues/2025/julyaugust/real-world-ophthalmology-corner/.

07/21/2025

Here’s a glimpse at what’s in our latest issue!

Be sure to read the full issue here: https://digital.ophthalmologymanagement.com/publication/?i=848849.

07/18/2025

What happened this week in Ophthalmology? Find out here: https://ophthalmologymanagement.com/news/2025/

07/17/2025

NEW QUIZ ALERT! Test your knowledge with VisionGenius – Ophthalmology! Sharpen your skills with new quizzes every Thursday highlighting ophthalmology research, news, trends, best practices, and more. Take this week’s quiz “Ligneous Conjunctivitis: Identifying a Hallmark Manifestation” right here: http://bit.ly/4nRDTen

07/17/2025

Enabling a smooth transition to new leadership is one of the most important tasks a successful ASC owner must manage.
Here's critical lessons from ASCs that have achieved it.

https://ophthalmologymanagement.com/supplements/2025/the-ophthalmic-asc-july/asc-succession-planning-smoothing-the-transition/

07/16/2025

Kevin J. Corcoran, Corcoran Consulting Group, explains how to code photobiomodulation (PBM) of the retina.

Read the full article here: https://ophthalmologymanagement.com/issues/2025/julyaugust/coding-and-reimbursement/

07/15/2025

Tuesday Tip: For practice leaders, mastering cross-generational communication isn’t just a soft skill—it’s a strategic necessity. To bridge any gaps and improve team efficiency, make it a point to learn the general preferences of your team members. This doesn’t mean stereotyping; notice communication patterns and ask about preferences directly.

To learn more about mastering cross-generational communication, read the full article by Christa Shephard and Ally Stemen, VMG Health: https://ophthalmologymanagement.com/issues/2025/julyaugust/best-practices/

07/14/2025

Optogenetics has made remarkable progress since its inception in 2004, with multiple clinical trials spanning different approaches to address inherited retinal disease in a gene-agnostic fashion. As this technology matures, optogenetics will expand treatment options for those affected by devastating inherited retinal degeneration.

Read the full article by Lauren M. Ciulla, MD, and Thomas A. Ciulla, M.D., at our website: https://ophthalmologymanagement.com/issues/2025/julyaugust/the-optimism-of-optogenics/.

AbbVie
Nanoscope Therapeutics
Roche

Several companies are sponsoring clinical development of optogenetic therapies, each with distinct approaches and technologies.

07/11/2025

Are you receiving our enewsletters? Click here to sign up: https://ophthalmologymanagement.com/newsletter-signup/

07/10/2025

Test your knowledge with VisionGenius – Ophthalmology! Sharpen your skills with new quizzes every Thursday highlighting ophthalmology research, news, trends, best practices, and more. Take this week’s quiz “Treatment for Ligneous Conjunctivitis” right here: https://bit.ly/4nuFTJi

07/10/2025

Conducting clinical trials in your ASC allows the facility to position itself as a leading center for new and innovative techniques and devices, and allows the staff to feel that they are contributing to the field of science. Here's how to make them work.

https://ophthalmologymanagement.com/supplements/2025/the-ophthalmic-asc-july/bring-clinical-research-into-your-asc/

07/10/2025

Alcon announced it will acquire LumiThera, Inc, a developer of photobiomodulation (PBM) therapy for dry AMD, in a move that broadens its retinal treatment portfolio beyond surgery. Learn more here: https://ow.ly/Ca4N50WnyRR.